GSK Eyeing Consumer Healthcare Units Of Pfizer And Merck

Alongside a third-quarter trading update on October 25th, the Chief Executive of GlaxoSmithKline (GSK) admitted that the British group could be interested in acquiring the consumer healthcare arms of US rival Pfizer and Germany’s Merck. (More)

• Given GSK current market cap of £70bn, acquisition of Pfizer’s consumer division (£11bn) and Merck division (£3bn) would be significant acquisitions…
• ....Resulting in the acquired brands being driven hard…

Therefore no harm in competitors conducting what-ifs re the possible changes, just-in-case…